• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名弹性假黄瘤患者成功进行了足部旁路手术。

Successful Pedal Bypass in a Patient With Pseudoxanthoma Elasticum.

作者信息

Väärämäki Suvi, Hautero Olli, Rajala Vesa, Nevalainen Pasi

机构信息

Centre for Vascular Surgery, Tampere University Hospital, Faculty of Medicine and Life Sciences, Tampere, Finland.

Department of Vascular Surgery, Vaasa Central Hospital, Vaasa, Finland.

出版信息

Vasc Endovascular Surg. 2025 Apr;59(3):315-319. doi: 10.1177/15385744241290007. Epub 2024 Oct 13.

DOI:10.1177/15385744241290007
PMID:39397377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11804138/
Abstract

OBJECTIVES

Pseudoxanthoma elasticum (PXE) is a rare metabolic disease, causing calcification in the arterial media layer and further peripheral artery disease (PAD). A high rate of failure has been reported after endovascular and open surgical management of PAD among patients with PXE. Critical limb ischemia (CLI) rarely develops in PXE, and there are only few reports of its treatment.

METHODS

We present a case report of a 57 year-old female diagnosed with pseudoxanthoma elasticum (PXE). She presented with critical limb ischemia (CLI) and was successfully treated with pedal bypass using the great saphenous vein.

RESULTS

Despite obtaining suboptimal outcomes through the initial approach of percutaneous transluminal angioplasty to treat critical limb ischemia, the subsequent bypass operation proved to be a success. At the first follow-up appointment at 1 month, the patient was asymptomatic and the ulceration had almost healed. The patient underwent an ultrasound examination at 3, 6, 12, and 24 months after discharge, and the surveillance was uncomplicated.

CONCLUSIONS

With a clear indication for surgery, limb-threatening ischemia can be successfully treated with distal bypass, if necessary, in patients with PXE similarly to atherosclerotic PADs. Appropriate diagnostic and surveillance imaging and the utilization of a multidisciplinary team are key components for effective management of PAD in patients with PXE.

摘要

目的

弹性假黄瘤(PXE)是一种罕见的代谢性疾病,可导致动脉中膜层钙化并进而引发外周动脉疾病(PAD)。据报道,PXE患者的PAD在接受血管内治疗和开放手术治疗后失败率很高。PXE很少发生严重肢体缺血(CLI),关于其治疗的报道也很少。

方法

我们报告一例57岁女性被诊断为弹性假黄瘤(PXE)的病例。她出现了严重肢体缺血(CLI),并通过大隐静脉进行足部搭桥手术成功治疗。

结果

尽管通过经皮腔内血管成形术治疗严重肢体缺血的初始方法取得的效果欠佳,但随后的搭桥手术被证明是成功的。在术后1个月的首次随访中,患者无症状,溃疡几乎愈合。患者在出院后3、6、12和24个月接受了超声检查,监测过程无并发症。

结论

对于有明确手术指征的患者,与动脉粥样硬化性PAD患者类似,必要时,PXE患者的肢体威胁性缺血可通过远端搭桥手术成功治疗。适当的诊断和监测成像以及多学科团队的利用是有效管理PXE患者PAD的关键组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711a/11804138/a134415b002e/10.1177_15385744241290007-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711a/11804138/f3ec179efd66/10.1177_15385744241290007-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711a/11804138/a134415b002e/10.1177_15385744241290007-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711a/11804138/f3ec179efd66/10.1177_15385744241290007-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711a/11804138/a134415b002e/10.1177_15385744241290007-fig2.jpg

相似文献

1
Successful Pedal Bypass in a Patient With Pseudoxanthoma Elasticum.一名弹性假黄瘤患者成功进行了足部旁路手术。
Vasc Endovascular Surg. 2025 Apr;59(3):315-319. doi: 10.1177/15385744241290007. Epub 2024 Oct 13.
2
Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum.弹性假黄瘤患者踝臂指数与动脉重构的关系。
J Vasc Surg. 2011 Nov;54(5):1390-4. doi: 10.1016/j.jvs.2011.04.041. Epub 2011 Jul 1.
3
Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.慢性肢体缺血高危患者的下肢动脉腔内治疗或手术治疗。
J Vasc Surg. 2024 Nov;80(5):1515-1524. doi: 10.1016/j.jvs.2024.05.049. Epub 2024 Jun 21.
4
Outcomes after open infrainguinal bypass in patients with scleroderma.硬皮病患者开放性下肢旁路术后的结局
J Vasc Surg. 2016 Jul;64(1):117-23. doi: 10.1016/j.jvs.2015.12.057. Epub 2016 Mar 19.
5
Preliminary six-month outcomes of LIMBSAVE (treatment of critical Limb IscheMia with infragenicular Bypass adopting in situ SAphenous VEin technique) registry.LIMBSAVE(采用原位大隐静脉技术治疗膝下动脉临界肢体缺血的旁路治疗)注册研究的初步 6 个月结果。
Vascular. 2021 Aug;29(4):589-596. doi: 10.1177/1708538120966126. Epub 2020 Oct 22.
6
Profunda Femoral to Anterior Tibial Artery Bypass to Treat Critical Limb Ischemia in a Patient with Numerous Prior Arterial Reconstructions.股深动脉至胫前动脉旁路移植术治疗一名既往多次接受动脉重建手术患者的严重肢体缺血
Eur J Vasc Endovasc Surg. 2016 Nov;52(5):702. doi: 10.1016/j.ejvs.2016.08.008. Epub 2016 Sep 2.
7
Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.股浅动脉腔内治疗联合腘动脉至远端旁路移植术的有效性:慢性肢体威胁性缺血手术开放旁路移植术的范式转变。
Vascular. 2021 Dec;29(6):905-912. doi: 10.1177/1708538120981224. Epub 2020 Dec 21.
8
Peripheral Interventions in Patients with Pseudoxanthoma Elasticum (PXE).弹性假黄瘤(PXE)患者的外周介入治疗。
Eur J Vasc Endovasc Surg. 2023 Jan;65(1):142-148. doi: 10.1016/j.ejvs.2022.08.009. Epub 2022 Aug 14.
9
Popliteal-distal bypass affords better limb salvage than tibial angioplasty for chronic limb-threatening ischemia.对于慢性肢体威胁性缺血,腘动脉-远端旁路移植术在保肢方面比胫动脉血管成形术效果更好。
J Vasc Surg. 2025 Feb;81(2):417-424.e1. doi: 10.1016/j.jvs.2024.10.011. Epub 2024 Oct 15.
10
Validation of BEST-CLI among patients undergoing primary bypass or angioplasty with or without stenting for chronic limb-threatening ischemia.在接受初次搭桥或血管成形术(无论是否置入支架)治疗慢性肢体威胁性缺血的患者中对BEST-CLI进行验证。
J Vasc Surg. 2025 May;81(5):1138-1147.e2. doi: 10.1016/j.jvs.2025.01.009. Epub 2025 Jan 16.

本文引用的文献

1
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的手术或血管内治疗。
N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7.
2
Peripheral Interventions in Patients with Pseudoxanthoma Elasticum (PXE).弹性假黄瘤(PXE)患者的外周介入治疗。
Eur J Vasc Endovasc Surg. 2023 Jan;65(1):142-148. doi: 10.1016/j.ejvs.2022.08.009. Epub 2022 Aug 14.
3
Various vascular malformations are prevalent in Finnish pseudoxanthoma elasticum (PXE) patients: a national registry study.
芬兰假性黄色瘤弹性组织营养不良(PXE)患者中存在多种血管畸形:一项全国性登记研究。
Orphanet J Rare Dis. 2022 May 7;17(1):185. doi: 10.1186/s13023-022-02341-6.
4
Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure: A Population Study.糖尿病是心力衰竭发展的独立预测因素:一项人群研究。
Mayo Clin Proc. 2020 Jan;95(1):124-133. doi: 10.1016/j.mayocp.2019.07.008.
5
Abnormally high failure rate for femoral angioplasty in patients with pseudoxanthoma elasticum.弹性假黄瘤患者股动脉血管成形术的失败率异常高。
J Vasc Surg Cases. 2015 Dec 17;1(4):276-278. doi: 10.1016/j.jvsc.2015.10.001. eCollection 2015 Dec.
6
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.下肢慢性肢体威胁性缺血血运重建结局的系统评价和荟萃分析。
J Vasc Surg. 2018 Aug;68(2):624-633. doi: 10.1016/j.jvs.2018.01.066. Epub 2018 May 24.
7
The prevalence of pseudoxanthoma elasticum: Revised estimations based on genotyping in a high vascular risk cohort.弹性假黄瘤的患病率:基于高血管风险队列基因分型的修订估计值。
Eur J Med Genet. 2019 Feb;62(2):90-92. doi: 10.1016/j.ejmg.2018.05.020. Epub 2018 May 22.
8
Oral administration of pyrophosphate inhibits connective tissue calcification.口服焦磷酸盐可抑制结缔组织钙化。
EMBO Mol Med. 2017 Nov;9(11):1463-1470. doi: 10.15252/emmm.201707532.
9
Pseudoxanthoma elasticum.弹性假黄瘤
Orphanet J Rare Dis. 2017 May 10;12(1):85. doi: 10.1186/s13023-017-0639-8.
10
Prevalence and severity of arterial calcifications in pseudoxanthoma elasticum (PXE) compared to hospital controls. Novel insights into the vascular phenotype of PXE.与医院对照组相比,弹性假黄瘤(PXE)中动脉钙化的患病率和严重程度。对PXE血管表型的新见解。
Atherosclerosis. 2017 Jan;256:7-14. doi: 10.1016/j.atherosclerosis.2016.11.012. Epub 2016 Nov 13.